AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
(Z)-2-(HYDROXYMETHYLCYCLOPROPYLIDENE)METHYLPURINES AND (E)-2-(HYDROXYMETHYLCYCLOPROPYLIDENE)METHYLPURINES AND PYRIMIDINES AS ANTIVIRAL AGENTS
Authors: QIU YL PTAK RG BREITENBACH JM LIN JS CHENG YC KERN ER DRACH JC ZEMLICKA J
Citation: Yl. Qiu et al., (Z)-2-(HYDROXYMETHYLCYCLOPROPYLIDENE)METHYLPURINES AND (E)-2-(HYDROXYMETHYLCYCLOPROPYLIDENE)METHYLPURINES AND PYRIMIDINES AS ANTIVIRAL AGENTS, Antiviral chemistry & chemotherapy, 9(4), 1998, pp. 341-352
SUMMARY OF THE II INTERNATIONAL-SYMPOSIUM ON CYTOMEGALOVIRUS
Authors: DEJONG MD GALASSO GJ GAZZARD B GRIFFITHS PD JABS DA KERN ER SPECTOR SA
Citation: Md. Dejong et al., SUMMARY OF THE II INTERNATIONAL-SYMPOSIUM ON CYTOMEGALOVIRUS, Antiviral research, 39(3), 1998, pp. 141-162
ASSESSMENT OF CORRELATION BETWEEN SKIN TARGET SITE FREE DRUG CONCENTRATION AND THE IN-VIVO TOPICAL ANTIVIRAL EFFICACY IN HAIRLESS MICE FOR (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE AND ACYCLOVIR FORMULATIONS
Authors: AFOUNA MI MEHTA SC GHANEM AH HIGUCHI WI KERN ER DECLERCQ E ELSHATTAWY HH
Citation: Mi. Afouna et al., ASSESSMENT OF CORRELATION BETWEEN SKIN TARGET SITE FREE DRUG CONCENTRATION AND THE IN-VIVO TOPICAL ANTIVIRAL EFFICACY IN HAIRLESS MICE FOR (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE AND ACYCLOVIR FORMULATIONS, Journal of pharmaceutical sciences, 87(8), 1998, pp. 917-921
)-2-((HYDROXYMETHYL)CYCLOPROPYLIDENE)METHYLADENINE AND )-2-((HYDROXYMETHYL)CYCLOPROPYLIDENE)METHYLGUANINE AND )-2-((HYDROXYMETHYL)CYCLOPROPYLIDENE)METHYLADENINE AND )-2-((HYDROXYMETHYL)CYCLOPROPYLIDENE)METHYLGUANINE - NEW NUCLEOSIDE ANALOGS WITH A BROAD-SPECTRUM ANTIVIRAL ACTIVITY
Authors: QIU YL KSEBATI MB PTAK RG FAN BY BREITENBACH JM LIN JS CHENG YC KERN ER DRACH JC ZEMLICKA J
Citation: Yl. Qiu et al., )-2-((HYDROXYMETHYL)CYCLOPROPYLIDENE)METHYLADENINE AND )-2-((HYDROXYMETHYL)CYCLOPROPYLIDENE)METHYLGUANINE AND )-2-((HYDROXYMETHYL)CYCLOPROPYLIDENE)METHYLADENINE AND )-2-((HYDROXYMETHYL)CYCLOPROPYLIDENE)METHYLGUANINE - NEW NUCLEOSIDE ANALOGS WITH A BROAD-SPECTRUM ANTIVIRAL ACTIVITY, Journal of medicinal chemistry, 41(1), 1998, pp. 10-23
EVALUATION OF A LIVE ATTENUATED RECOMBINANT VIRUS RAV-9395 AS A HERPES-SIMPLEX VIRUS TYPE-2 VACCINE IN GUINEA-PIGS
Authors: SPECTOR FC KERN ER PALMER J KAIWAR R CHA TA BROWN P SPAETE RR
Citation: Fc. Spector et al., EVALUATION OF A LIVE ATTENUATED RECOMBINANT VIRUS RAV-9395 AS A HERPES-SIMPLEX VIRUS TYPE-2 VACCINE IN GUINEA-PIGS, The Journal of infectious diseases, 177(5), 1998, pp. 1143-1154
CHRONIC VULVAR ULCERATION IN AN IMMUNOCOMPETENT WOMAN DUE TO ACYCLOVIR-RESISTANT, THYMIDINE KINASE-DEFICIENT HERPES-SIMPLEX VIRUS
Authors: SWETTER SM HILL EL KERN ER KOELLE DM POSAVAD CM LAWRENCE W SAFRIN S
Citation: Sm. Swetter et al., CHRONIC VULVAR ULCERATION IN AN IMMUNOCOMPETENT WOMAN DUE TO ACYCLOVIR-RESISTANT, THYMIDINE KINASE-DEFICIENT HERPES-SIMPLEX VIRUS, The Journal of infectious diseases, 177(3), 1998, pp. 543-550
APOPTOSIS MEDIATED BY FAS BUT NOT TUMOR-NECROSIS-FACTOR RECEPTOR-1 PREVENTS CHRONIC DISEASE IN MICE INFECTED WITH MURINE CYTOMEGALOVIRUS
Authors: FLECK M KERN ER ZHOU T PODLECH J WINTERSBERGER W EDWARDS CK MOUNTZ JD
Citation: M. Fleck et al., APOPTOSIS MEDIATED BY FAS BUT NOT TUMOR-NECROSIS-FACTOR RECEPTOR-1 PREVENTS CHRONIC DISEASE IN MICE INFECTED WITH MURINE CYTOMEGALOVIRUS, The Journal of clinical investigation, 102(7), 1998, pp. 1431-1443
TREATMENT OF CHRONIC SIALADENITIS IN A MURINE MODEL OF SJOGRENS-SYNDROME BY LOCAL FAS LIGAND GENE-TRANSFER
Authors: FLECK M ZHANG HG KERN ER SCHOLMERICH J MOUNTZ JD
Citation: M. Fleck et al., TREATMENT OF CHRONIC SIALADENITIS IN A MURINE MODEL OF SJOGRENS-SYNDROME BY LOCAL FAS LIGAND GENE-TRANSFER, Arthritis and rheumatism, 41(9), 1998, pp. 1763-1763
THE SYNTHESIS AND IMMUNOGENICITY OF VARICELLA-ZOSTER VIRUS GLYCOPROTEIN-E AND IMMEDIATE-EARLY PROTEIN (IE62) EXPRESSED IN RECOMBINANT HERPES-SIMPLEX VIRUS-1
Authors: LOWRY PW KOROPCHAK CM CHOI CYH MOCARSKI ES KERN ER KINCHINGTON PR ARVIN AM
Citation: Pw. Lowry et al., THE SYNTHESIS AND IMMUNOGENICITY OF VARICELLA-ZOSTER VIRUS GLYCOPROTEIN-E AND IMMEDIATE-EARLY PROTEIN (IE62) EXPRESSED IN RECOMBINANT HERPES-SIMPLEX VIRUS-1, Antiviral research, 33(3), 1997, pp. 187-200
RELATIONSHIP OF SKIN TARGET SITE FREE DRUG CONCENTRATION (C-ASTERISK)TO THE IN-VIVO EFFICACY - AN EXTENSIVE EVALUATION OF THE PREDICTIVE VALUE OF THE CC CONCEPT USING ACYCLOVIR AS A MODEL-DRUG
Authors: MEHTA SC AFOUNA MI GHANEM AH HIGUCHI WI KERN ER
Citation: Sc. Mehta et al., RELATIONSHIP OF SKIN TARGET SITE FREE DRUG CONCENTRATION (C-ASTERISK)TO THE IN-VIVO EFFICACY - AN EXTENSIVE EVALUATION OF THE PREDICTIVE VALUE OF THE CC CONCEPT USING ACYCLOVIR AS A MODEL-DRUG, Journal of pharmaceutical sciences, 86(7), 1997, pp. 797-801
A NEW MODEL FOR SJOGRENS-SYNDROME AND AUTOIMMUNE-DISEASE IN LPR MICE INDUCED BY MURINE CYTOMEGALOVIRUS-INFECTION
Authors: FLECK M KERN ER ZHOU T WINTERSBERGER W EDWARDS CK MOUNTZ JD
Citation: M. Fleck et al., A NEW MODEL FOR SJOGRENS-SYNDROME AND AUTOIMMUNE-DISEASE IN LPR MICE INDUCED BY MURINE CYTOMEGALOVIRUS-INFECTION, Arthritis and rheumatism, 40(9), 1997, pp. 1165-1165
DIFFERENTIAL EFFECT OF RECOMBINANT HUMAN AND MOUSE INTERFERONS ON REPLICATION OF HERPES-SIMPLEX VIRUS TYPE-1 IN MOUSE CELLS
Authors: WINTERGERST U GANGEMI JD KERN ER WHITLEY RJ CHATTERJEE S
Citation: U. Wintergerst et al., DIFFERENTIAL EFFECT OF RECOMBINANT HUMAN AND MOUSE INTERFERONS ON REPLICATION OF HERPES-SIMPLEX VIRUS TYPE-1 IN MOUSE CELLS, Antiviral research, 32(1), 1996, pp. 27-34
CORRELATION OF IN-VIVO TOPICAL EFFICACIES WITH IN-VITRO PREDICTIONS USING ACYCLOVIR FORMULATIONS IN THE TREATMENT OF CUTANEOUS HSV-1 INFECTIONS IN HAIRLESS MICE - AN EVALUATION OF THE PREDICTIVE VALUE OF THE C-ASTERISK CONCEPT
Authors: PATEL PJ GHANEM AH HIGUCHI WI SRINIVASAN V KERN ER
Citation: Pj. Patel et al., CORRELATION OF IN-VIVO TOPICAL EFFICACIES WITH IN-VITRO PREDICTIONS USING ACYCLOVIR FORMULATIONS IN THE TREATMENT OF CUTANEOUS HSV-1 INFECTIONS IN HAIRLESS MICE - AN EVALUATION OF THE PREDICTIVE VALUE OF THE C-ASTERISK CONCEPT, Antiviral research, 29(2-3), 1996, pp. 279-286
CONSENSUS SYMPOSIUM ON COMBINED ANTIVIRAL THERAPY
Authors: KERN ER RICHMAN DD
Citation: Er. Kern et Dd. Richman, CONSENSUS SYMPOSIUM ON COMBINED ANTIVIRAL THERAPY, Antiviral research, 29(1), 1996, pp. 3-3
CONSENSUS SYMPOSIUM ON COMBINED ANTIVIRAL THERAPY
Authors: DEJONG MD BOUCHER CAB GALASSO GJ HIRSCH MS KERN ER LANGE JMA RICHMAN DD
Citation: Md. Dejong et al., CONSENSUS SYMPOSIUM ON COMBINED ANTIVIRAL THERAPY, Antiviral research, 29(1), 1996, pp. 5-29
ROLE OF ANIMAL-MODELS IN SELECTING ANTIVIRAL COMBINATIONS FOR CLINICAL-STUDIES
Authors: KERN ER
Citation: Er. Kern, ROLE OF ANIMAL-MODELS IN SELECTING ANTIVIRAL COMBINATIONS FOR CLINICAL-STUDIES, Antiviral research, 29(1), 1996, pp. 57-59
ACYCLIC NUCLEOSIDE AND NUCLEOTIDE ANALOGS WITH AMIDE BOND
Authors: EFIMTSEVA EV MIKHAILOV SN JASKO MV MALAKHOV DV SEMIZAROV DG FOMICHEVA MV KERN ER
Citation: Ev. Efimtseva et al., ACYCLIC NUCLEOSIDE AND NUCLEOTIDE ANALOGS WITH AMIDE BOND, Nucleosides & nucleotides, 14(3-5), 1995, pp. 373-375
MODELS OF ANTIVIRAL RESISTANCE
Authors: KIMBERLIN DW KERN ER SIDWELL RW NORTH TW WHITLEY RJ
Citation: Dw. Kimberlin et al., MODELS OF ANTIVIRAL RESISTANCE, Antiviral research, 26(4), 1995, pp. 415-422
ACYCLIC NUCLEOSIDE ANALOGS WITH AMIDE BON D
Authors: MIKHAILOV SN EFIMTSEVA EV FOMICHEVA MV RODIONOV MS KERN ER
Citation: Sn. Mikhailov et al., ACYCLIC NUCLEOSIDE ANALOGS WITH AMIDE BON D, Bioorganiceskaa himia, 21(2), 1995, pp. 130-132
SYNTHESIS AND ANTIPROLIFERATIVE AND ANTIVIRAL ACTIVITY OF 2'-DEOXY-2'-FLUOROARABINOFURANOSYL ANALOGS OF THE NUCLEOSIDE ANTIBIOTICS TOYOCAMYCIN AND SANGIVAMYCIN
Authors: KRAWCZYK SH NASSIRI MR KUCERA LS KERN ER PTAK RG WOTRING LL DRACH JC TOWNSEND LB
Citation: Sh. Krawczyk et al., SYNTHESIS AND ANTIPROLIFERATIVE AND ANTIVIRAL ACTIVITY OF 2'-DEOXY-2'-FLUOROARABINOFURANOSYL ANALOGS OF THE NUCLEOSIDE ANTIBIOTICS TOYOCAMYCIN AND SANGIVAMYCIN, Journal of medicinal chemistry, 38(20), 1995, pp. 4106-4114
NUCLEOSIDE ANALOGS ON THE BASIS OF 4(R),5(R)-DIHYDROXYMETHYL-2-METHYL-1,3-DIOXOLANE
Authors: MIKHAILOV SN EFIMTSEVA EV MESHKOV SV KERN ER
Citation: Sn. Mikhailov et al., NUCLEOSIDE ANALOGS ON THE BASIS OF 4(R),5(R)-DIHYDROXYMETHYL-2-METHYL-1,3-DIOXOLANE, Nucleosides & nucleotides, 13(1-3), 1994, pp. 615-623
ESTIMATION OF SKIN TARGET SITE ACYCLOVIR CONCENTRATIONS FOLLOWING CONTROLLED (TRANS)DERMAL DRUG-DELIVERY IN TOPICAL AND SYSTEMIC TREATMENT OF CUTANEOUS HSV-1 INFECTIONS IN HAIRLESS MICE
Authors: IMANIDIS G SONG WQ LEE PH SU MH KERN ER HIGUCHI WI
Citation: G. Imanidis et al., ESTIMATION OF SKIN TARGET SITE ACYCLOVIR CONCENTRATIONS FOLLOWING CONTROLLED (TRANS)DERMAL DRUG-DELIVERY IN TOPICAL AND SYSTEMIC TREATMENT OF CUTANEOUS HSV-1 INFECTIONS IN HAIRLESS MICE, Pharmaceutical research, 11(7), 1994, pp. 1035-1041
AN APPLICATION OF TRANSDERMAL ANTIVIRAL DELIVERY SYSTEMS TO THE ESTABLISHMENT OF A NOVEL ANIMAL-MODEL APPROACH IN THE EFFICACY EVALUATION FOR DERMATOLOGICAL FORMULATIONS
Authors: SU MH LEE PH GHANEM AH KERN ER HIGUCHI WI
Citation: Mh. Su et al., AN APPLICATION OF TRANSDERMAL ANTIVIRAL DELIVERY SYSTEMS TO THE ESTABLISHMENT OF A NOVEL ANIMAL-MODEL APPROACH IN THE EFFICACY EVALUATION FOR DERMATOLOGICAL FORMULATIONS, Drug development and industrial pharmacy, 20(4), 1994, pp. 685-718
EFFICACY OF A-73209, A POTENT ORALLY-ACTIVE AGENT AGAINST VZV AND HSVINFECTIONS
Authors: ALDER J MITTEN M NORBECK D MARSH K KERN ER CLEMENT J
Citation: J. Alder et al., EFFICACY OF A-73209, A POTENT ORALLY-ACTIVE AGENT AGAINST VZV AND HSVINFECTIONS, Antiviral research, 23(2), 1994, pp. 93-105
PENCICLOVIR - A REVIEW OF ITS SPECTRUM OF ACTIVITY, SELECTIVITY, AND CROSS-RESISTANCE PATTERN
Authors: BOYD MR SAFRIN S KERN ER
Citation: Mr. Boyd et al., PENCICLOVIR - A REVIEW OF ITS SPECTRUM OF ACTIVITY, SELECTIVITY, AND CROSS-RESISTANCE PATTERN, Antiviral chemistry & chemotherapy, 4, 1993, pp. 3-11
Risultati: 1-25 | 26-30